The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

LifeMD offers a $299 bundle for new self-pay patients prescribed Wegovy®, including medication and virtual weight management support. LifeMD, Inc. has introduced a limited-time $299 bundle for new ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

LAS VEGAS—Highmark is teaming up with Noom to roll out its weight management solution to members. Eligible members can enroll in the program and will receive Noom's services at no cost. Their care ...

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program could run into problems with voluntary participation and concerns about ...

Without the right support to supplement GLP-1 medication benefit offerings like Ozempic and Wegovy, organizations are missing out on the potential of any weight loss solution they offer now or in the ...

A successful strategy needs to integrate weight management into an employee benefits program and support the behavior changes ...

Diet weight loss company Noom announced it is launching a new program dubbed the Noom Microdose GLP-1Rx Program, which will provide members with personalized microdoses of GLP-1 medication. The ...

The announcement comes as GLP-1 receptor agonist medications, a class of FDA-approved therapies used to treat obesity by ...

PORTSMOUTH, Va. (WAVY) — The holidays are here and with it comes unwanted extra weight and can be hard to eliminate. There are lots of options available for weight loss, but it’s important to stay ...

Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the ...